Explore By Subject Area   
Return Home
Register Here Menu

PODD: Partnerships in Drug Delivery

Date: Oct 27, 2025 - Oct 28, 2025

Location: Boston, MA

Day One: Monday, October 27, 2025
Showing Events in 1 Track from 07:30am to 08:10am
Registration
7:30AM - 8:10AM
Registration
Showing Events in 1 Track from 08:10am to 08:20am
Opening Remarks
8:10AM - 8:20AM
Co-Chairs’ Opening Remarks
Co-Chairs:
Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership
Sherri Biondi, PhD, Executive Director and Head of Device Development, AstraZeneca
Beate Bittner, PhD, Head Product Optimization, Roche
Showing Events in 1 Track from 08:20am to 08:40am
Morning General Session
8:20AM - 8:40AM
Roche’s Industry Overview on the Drug Delivery Landscape 2025
Speaker:
Beate Bittner, PhD, Head Product Optimization, Roche
Showing Events in 1 Track from 08:40am to 09:05am
Opening Keynote
8:40AM - 9:05AM
Opening Keynote with Novo Nordisk’s Chief Scientific Advisor Who Drove the Development of GLP-1 Drugs for Obesity
Speaker:
Lotte Bjerre Knudsen, DMSc, Chief Scientific Advisor, Novo Nordisk
Showing Events in 1 Track from 09:05am to 09:30am
Annual Keynote
9:05AM - 9:30AM
Keynote Innovation Leadership
Speakers:
Robert Langer, ScD, David H. Koch Institute Professor, MIT
Showing Events in 1 Track from 09:30am to 09:45am
Morning General Session Continued
9:30AM - 9:45AM
What's So Special About Specialty Delivery?
Speaker:
Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership
Showing Events in 1 Track from 09:45am to 10:35am
PODD Grand Opening Networking Break & Partnering
9:45AM - 10:35AM
PODD Grand Opening Networking Break & Partnering
Showing Events in 1 Track from 10:35am to 12:25pm
Morning General Session Continued
10:35AM - 10:55AM
A Breath of Opportunities: The Future of Inhaled Biologics
Speaker:
Mireia Puig-Sellart, PharmD, PhD, Manager, Pharmaceutical Development, Phillips Medisize
10:55AM - 11:25AM
Pharma Company Spotlights
Speakers:
Mateja Kramer, PhD, Global Head of Innovation, Novartis
Nicholas Schill, PhD, Senior Director, Landscaping & Platform Definition; Device & Combination Product Development, AbbVie
11:25AM - 11:40AM
Emerging Design Space Requirements in High-Dose Drug Development Pipeline: Dynamics, Challenges and Potential Technology Pathways
Speaker:
Beth McBride DiLauri, Director, Global Marketing, BD
11:40AM - 12:10PM
Partnering to Advance Drug Delivery Innovation
Moderated by:
Ester Caffarel-Salvador, PhD, Director, Strategic Innovation, Chiesi USA
Panelists:
Annette Bak, PhD, MBA, Head of Advanced Drug Delivery, AstraZeneca
Sean Bedingfield, PhD, R&D Advisor - Genetic Medicine, Eli Lilly and Company
Jaymin Shah, PhD, Senior Research Fellow and Head of Biopharmaceutics, Pfizer
Rashmi Thakur, Director, Portfolio Strategy & Integration, BMS
12:10PM - 12:25PM
Reserved Session
Showing Events in 1 Track from 12:25pm to 01:25pm
Luncheon & Partnering Meetings
12:25PM - 1:25PM
Luncheon & Partnering Meetings
Showing Events in 1 Track from 01:25pm to 06:25pm
The 15th Annual PODD Drug Delivery Technology Presentations in Ten Tracks
1:25PM - 6:25PM
The 15th Annual PODD Drug Delivery Technology Presentations in Ten Tracks, to See All Tracks Click the Red Side Arrow Below
Showing Events in 5 Tracks from 01:30pm to 03:52pm
1A: Injectable Formulations & Technologies
Chaired by:
Manish Gupta, PhD, Executive Director R&D, Drug Product Development - Steriles, GSK
1:30PM - 1:45PM
InnoMedica's Liposomal GM1 Drug Against Neurodegenerative Diseases
Speaker:
Andreas Zumbuehl, Scientific Specialist, InnoMedica
1:45PM - 2:00PM
West
2:00PM - 2:15PM
Nanomi’s Multi-Indication Growth Engine to Develop Tailor Made Long Acting Injectables in Pharma
Speaker:
Okke Franssen, PhD, CEO, Nanomi
2:15PM - 2:30PM
Chroniject Technology: A Solution to Long Acting Injectable Formulation and Scale-Up Challenges
Speaker:
Colin Spencer, Head of Technology Transfer, Project Manager, Oakwood Labs
2:30PM - 2:45PM
Simplify to Scale: Reducing Complexity in Dual Drug Formulation and Delivery
Speaker:
Nicolas Bralet, Associate Business Director, Biologics PFS, BD
2:45PM - 3:00PM
Beyond Materials: Corbion as Your Trusted Partner in Innovative Drug Delivery
Speaker:
Bahar Yeniad, PhD, Global Senior Business Development Manager, Corbion
3:00PM - 3:15PM
SynBiosys®: Long-Acting Injectable Microspheres and In Situ Forming Depots for Delivery of Peptides and Proteins
Speaker:
Rob Steendam, PhD, Chief Technology Officer, InnoCore
3:15PM - 3:30PM
Clinical Data on Once-Monthly GLP-1 Formulation Using the PharmaShell Drug Delivery System
Speaker:
David Westberg, CEO, Nanexa
3:30PM - 3:45PM
The Progress in New Drug and Therapy Development Inspire Innovations in Drug Delivery Technologies
Speaker:
Lukasz Koroniak, Global Biomaterial Director Drug Delivery Solutions, dsm-firmenich
3:45PM - 3:52PM
Ripple Therapeutics
Speaker:
Wendy Naimark, PhD, CTO & Co-Founder, Ripple Therapeutics
2A: Oral, Nasal, Pulmonary & Other Non-Injectable Technologies
Chaired by:
Parthiban Rajasekaran, DVM, PhD, Innovation Lead, Sanofi
1:30PM - 1:45PM
Strategic Pipeline Development with Neoliposomal™ Delivery: A Versatile Platform for Enhanced Drug Delivery and Bioavailability
Speaker:
TR Thirucote, Chairman & CEO, TesoRX
1:45PM - 2:00PM
Tailoring Controlled Release of Small Molecules and Biologics via Innovative High-Throughput Electrohydrodynamic Processing
Speaker:
Jose Lagaron, CEO/CSO, BioNanoPharma
2:00PM - 2:15PM
Alginate Oligosaccharide Platform: A Peptide & LNP Delivery Solution for Oral and Inhaled Routes
Speaker:
Yngve Mikkelsen, Chief Medical Officer, AlgiPharma AS
2:15PM - 2:30PM
Tailored Solutions and End-to-End Development for Your Drug–Nebulizer Combination Product
Speaker:
Chris Vernall, EVP Business Development, HCMed
2:30PM - 2:45PM
Syntis Bio
2:45PM - 3:00PM
ARx
3:00PM - 3:15PM
Open Session
3:15PM - 3:30PM
Open Session
3:30PM - 3:45PM
Open Session
3:45PM - 3:52PM
Therakind
3A: Novel Devices: Self-Injectables, Wearables & Connected Devices
Chaired by:
Ulrich Brüggemann, Lead Advanced Drug Delivery Technical Development, Takeda Pharmaceuticals
1:30PM - 1:45PM
Aktiv
1:45PM - 2:00PM
Transforming Chronic Care: How Connected Autoinjectors Improve Outcomes
Speaker:
Greg Panebianco, Sr. Director of Engineering & Customer Success, Flex
2:00PM - 2:15PM
Thinking Outside the Vial: Truly Integrated Drug-Device Developments
Speaker:
Fran Pencliffe, MEng, Healthcare Device Engineer, Cambridge Design Partnership
2:15PM - 2:30PM
Haselmeier
2:30PM - 2:45PM
TTP
2:45PM - 3:00PM
Connected Auto-injectors: Driving Innovation in Drug Delivery and Patient Adherence
Speaker:
Ilan Shopen, Director of Marketing and Business Development, E3D – Elcam Drug Delivery Devices
3:00PM - 3:15PM
A Configurable Patient-Centric autoinjector platform for High Viscosity and Large Volume Delivery
Speakers:
Pete Evans, Director of Device Development, SMC LTD
Asmita Khanolkar, Senior Director, SMC LTD
3:15PM - 3:30PM
Congruence Medical
3:30PM - 3:45PM
Pioneering Ocular Encapsulated Cell Therapy: Integrating Human Factors in the Development of ENCELTO
Speaker:
Claire Young, Senior Human Factors Consultant, Team Consulting
3:45PM - 3:52PM
Smart, Low-Cost Reusable Devices Can Enable Ideal Drug Development TPP
Speaker:
Peter Stebbins, VP, Program and Business Development, Satio
4A: Cell, Gene & Novel Biologics Delivery
Chaired by:
Russell Johnson, PhD, Head of Delivery Sciences, Moderna
1:30PM - 1:45PM
Open Session
1:45PM - 2:00PM
Getting to Scale with Genetic Therapies
Speaker:
Tony Duong, PhD, Lead Drug Delivery Scientist, Battelle
2:00PM - 2:15PM
Formulation Development Platform for Ionizable Lipid Library
Speaker:
Sho Ueno, Research Scientist, NOF CORPORATION
2:15PM - 2:30PM
LipidSol - An Enabler for Delivery of Small Molecules and Biologics
Speaker:
Shaukat Ali, PhD, Senior Director, Scientific Affairs & Technical Marketing, Ascendia Pharmaceuticals
2:30PM - 2:45PM
Transforming Non-Viral Gene Delivery: SENS™ (Selectivity Enabling NanoShell) Unlocks Cell-Selective Targeting of Extrahepatic, and Diseased Tissues
Speaker:
Saudat Fadeyi, PhD, MBA, Head of Business Development & Strategy, Samyang
2:45PM - 3:00PM
Payload Delivery Using Poly(glycerol ester) Polymers
Speaker:
Brian Ginn, PhD, Manager, Biomaterials Research, Secant Group
3:00PM - 3:15PM
Nitto Biopharma
3:15PM - 3:30PM
Manufacturing and Analytical Platform - From pDNA and mRNA to LNP with Multiple Nucleic Acids Loads
Speaker:
Andreja Gramc Livk, Head of Process Analytics, Sartorius BIA Separations
3:30PM - 3:45PM
Open Session
3:45PM - 3:52PM
Non-Viral Genetic Medicine Delivery with polyNaut®: Targeted Polymer Nanovesicles for CNS and Immune Cells
Speaker:
Sam Barker, Chief Business Officer, ViaNautis Bio
5A: Novel Materials & Excipient Innovation
Chaired by:
Edel Mullen, PhD, MBA, BSc, Director Drug Product Technologies, Amgen
1:30PM - 1:45PM
Open Session
1:45PM - 2:00PM
New Long-Acting Injectables and Immunotherapy Therapies Run On Tunable Lactide/Glycolide Polymers
Speaker:
Thomas Tice, Senior Director, Strategic and Technical Marketing, Evonik
2:00PM - 2:15PM
BioHale® Sugars – Micro Molecules, Macro Impact on Biotherapeutics
Speaker:
Mark Wagner, Sales Manager, North America, BioHale Disaccharides and Dry Powder Inhalation, DFE Pharma
2:15PM - 2:30PM
Design for Biocompatibility Strategies for Novel Excipients
Speaker:
Rigwed Tatu, PhD, Extractables and Leachables Program Lead, PSN Labs
2:30PM - 2:45PM
Ligand
2:45PM - 3:00PM
Open Session
3:00PM - 3:15PM
Open Session
3:15PM - 3:30PM
Open Session
3:30PM - 3:45PM
Open Session
3:45PM - 3:52PM
Large Lipid Body (LLB) Technology for Rapid Formulation of Hydrophobic Drugs, and Advantages Over Liposomes
Speaker:
Thomas Kelleher, CEO, Xylome
Showing Events in 1 Track from 03:55pm to 04:10pm
15-Minute Ice Cream & Networking Break
3:55PM - 4:10PM
15-Minute Ice Cream & Networking Break
Showing Events in 5 Tracks from 04:15pm to 06:22pm
1B: Injectable Formulations & Technologies
Chaired by:
F. Javier Muñoz, PhD, MBA, Technology Evaluation Leader, F Hoffmann-La Roche
4:15PM - 4:30PM
G2G Bio
4:30PM - 4:45PM
Surf SnapShot™ Technology: Ultra-Concentrated Subcutaneous Biologics via Standard Manufacturing Processes
Speaker:
Bryan Mazlish, CEO, Surf Bio
4:45PM - 5:00PM
Lipoid
5:00PM - 5:15PM
Nitrogen Dioxide Sterilization, the Leading Alternative to Ethylene Oxide
Speaker:
David Opie, Senior Vice President of Research and Development, Noxilizer
5:15PM - 5:30PM
Overcoming Challenges in Injectable Formulations Through Excipient Choice, Featuring Long-Acting Injectables
Speaker:
Brad Minrovic, PhD, Technical Sales Account Manager, Pharmaceutical Injectables, Ashland Specialty Ingredients
5:30PM - 5:45PM
Launching the First Biosimilar in an On-Body Injector – Lessons From the Device Manufacturer
Speaker:
Andrei Yosef, PhD, President, LTS Device Technologies, LTS-Lohmann
5:45PM - 6:00PM
Curia Global
6:00PM - 6:15PM
DelSiTech
6:15PM - 6:22PM
The Emerging Role of Precision Nanoporous Silicon Dioxide in Drug Delivery
Speaker:
Michael Sailor, PhD, Chief Scientific Officer, SiCare Bio
2B: Novel Injectable & Non-Injectable Technologies
Chaired by:
Jill Steinbach-Rankins, PhD, Senior Associate Director, Innovation Technology, Boehringer Ingelheim
4:15PM - 4:30PM
PharmaJet
Speaker:
Dan Mallon, Senior Vice President, Corporate Development, PharmaJet
4:30PM - 4:45PM
DELOS Nanovesicle Technology for the Development and Manufacture of Nanomedicines: Two Case Studies in Long-Acting Injectables and Nucleic Acid Delivery
Speaker:
Carla Castellar, Scientific Manager, Nanomol
4:45PM - 5:00PM
Implantable Drug Delivery…Are We There Yet?
Speaker:
Breck Petrillo, Sr. Director, Commercial Business Development, Battelle
5:00PM - 5:15PM
Vitaldose® Long-Acting Drug Delivery to Address Unmet Needs in Parenteral and Ocular Applications: Durable and Biodegradable Platforms
Speaker:
Jeff Haley, PhD, Global Technology Manager: VitalDose® and Ateva® Polymers, Celanese
5:15PM - 5:30PM
AI-Driven Development of Biologic Long Acting Injectables
Speaker:
Karthik Raman, PhD, CEO, Persist AI
5:30PM - 5:45PM
Zephyrus Innovations
5:45PM - 6:00PM
Multiphysics Simulation and Specialized Testing in Combination Product Design & Verification: Reducing Patient Risk
Speakers:
Matthew Hancock, PhD, Principal, Veryst Engineering
Sean Teller, PhD, Principal, Veryst Engineering
6:00PM - 6:15PM
Development and Application of Drug Delivery System Platform based on Microfluidic Technologies
Speaker:
Chan Hee Chon, CTO, Inventage Lab
6:15PM - 6:22PM
Open Session – Emerging Company
3B: Novel Device Technologies
Chaired by:
Scott Gibson, Director, Global Operations Leadership, Obesity & Related Conditions, Amgen
4:15PM - 4:30PM
Exploiting the Benefits of Gas Power for Medical Devices: Capacity, Consistency & Control
Speaker:
Jack Auld, Co-CEO & Co-Founder, Altaviz
4:30PM - 4:45PM
Patient-First, Science-Driven: The Rise of Nasal Therapeutics
Speaker:
Reenal Gandhi, Director, Business Development, Aptar Pharma
4:45PM - 5:00PM
Bridging the Clinical to Commercial Gaps for Combination Products
Speakers:
Erik Ferrier, Device and Combination Products, Device & Packaging Technology, Manufacturing Sciences & Technology, BMS
Bill Welch, Executive Director Market Development, PCI Pharma Services
5:00PM - 5:15PM
Large Volume Drug Delivery Devices: Considerations for HCP and Patient Experience
Speaker:
Adam Edelhauser, Director of R&D, KORU Medical Systems
5:15PM - 5:30PM
Addressing the Unmet Need in High-Volume Subcutaneous Self-Administration
Speakers:
Yuki Takeuchi, Global Product Manager for the PLAJEX Ready-to-Fill syringe platform, Terumo
Michael Travanty, Vice President, Product Development Engineering, Halozyme
5:30PM - 5:45PM
A Novel Approach to Modelling Injector Performance and Break-Loose Extrusion Force Data
Speakers:
Deep Bhattacharya, PhD, Principal Scientist, Pfizer
Tom Oakley, Board Member and VP Design and Development,, Sanner Group
5:45PM - 6:00PM
Miniaturization Advancement for Scalable Production Previously Thought Unattainable: Molding Thin Wall Cannulas, Microfluidics, and Micro Needles
Speakers:
Brent Hahn, MBA, SVP, Isometric Micro Molding
6:00PM - 6:15PM
Secant Group
6:15PM - 6:22PM
Precision Matters: Advancing Drug Delivery for Novel Therapies
Speaker:
Steve Duddy, Co-Founder & CEO, Rheotek Medical
4B: Cell, Gene & Novel Biologics Delivery
Chaired by:
Junwei Li, PhD, Innovation Manager, Novo Nordisk
4:15PM - 4:30PM
AI-Designed Polymer Nanoparticles: A New Frontier in Gene Therapy
Speaker:
Shira Orr, PhD, Co-Founder and CEO, Envoya
4:30PM - 4:45PM
Nanoprimer Technology for Enhanced Therapeutic Delivery: Outsmarting the Liver Barrier
Speaker:
Julie Devalliere, PhD, Senior Manager, Biology Team, Nanobiotix
4:45PM - 5:00PM
Re-Vana Therapeutics
5:00PM - 5:15PM
Open Session
5:15PM - 5:30PM
Open Session
5:30PM - 5:45PM
Open Session
5:45PM - 6:00PM
Open Session
6:00PM - 6:15PM
Open Session
6:15PM - 6:22PM
QurCan Therapeutics
5B: Self-Injection Devices, Syringes, Primary Container & Packaging Solutions
Chaired by:
Srini Sridharan, PhD, Executive Director, Drug Delivery & Product Integration, Bristol-Myers Squibb
4:15PM - 4:30PM
Kindeva
4:30PM - 4:45PM
Advantages of a Delivery System Platform to Drug-Device Combination Product Development
Speaker:
Laxman Halleppanavar, Head of Portfolio Strategy and Management, Credence MedSystems
4:45PM - 5:00PM
De-Risking Autoinjector Integration with High-Performance Pre-Fillable Syringes
Speaker:
Alessio Bonati, Director Alba & Nexa Flex Programs, Stevenato Group
5:00PM - 5:15PM
Practical Strategy and Execution to Achieve Success with a Novel Combination Product
Speaker:
Jonathan Amaya-Hodges, Consulting Director, Suttons Creek
5:15PM - 5:30PM
OXYCAPT™ Vial & Syringe: High Gas Barrier Plastic Container for Biologics and Cell & Gene Therapy Products Sorted with Dry Ice or LN2
Speaker:
Masashi Miura, Researcher, Mitsubishi Gas Chemical
5:30PM - 5:45PM
The Design of a Large Volume PFS-Based Autoinjector Considering the Patient`s Perspective
Speakers:
Bernd Mahlmann, MBA, Associate Director, Account & Business Development, Ypsomed
Daniele Tartini, Sr. Business Development Manager – Glass Syringes, SCHOTT Pharma USA
5:45PM - 6:00PM
RPK
6:00PM - 6:15PM
Joined-Up Thinking: Combining Drug Product and Device Development and Manufacturing for a Fast and Assured Route to Market
Speaker:
Oliver Eden, MEng (Hons), PhD, Senior Business Unit Director, Jabil Healthcare
6:15PM - 6:22PM
Weiss-Aug/RX Bandz
Showing Events in 1 Track from 06:25pm to 07:30pm
PODD Networking Reception & Partnering Meetings
6:25PM - 7:30PM
PODD Networking Reception & Partnering Meetings
Showing Events in 1 Track from 07:30pm to 07:30pm
Day One Concludes
7:30PM - 7:30PM
Day One Concludes
Showing Events in 1 Track from 07:30am to 08:10am
Registration
7:30AM - 8:10AM
Registration
Showing Events in 1 Track from 08:10am to 08:20am
Opening Remarks
8:10AM - 8:20AM
Co-Chairs’ Opening Remarks
Co-Chairs:
Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership
Sherri Biondi, PhD, Executive Director and Head of Device Development, AstraZeneca
Beate Bittner, PhD, Head Product Optimization, Roche
Showing Events in 1 Track from 08:20am to 08:40am
Morning General Session
8:20AM - 8:40AM
Roche’s Industry Overview on the Drug Delivery Landscape 2025
Speaker:
Beate Bittner, PhD, Head Product Optimization, Roche
Showing Events in 1 Track from 08:40am to 09:05am
Opening Keynote
8:40AM - 9:05AM
Opening Keynote with Novo Nordisk’s Chief Scientific Advisor Who Drove the Development of GLP-1 Drugs for Obesity
Speaker:
Lotte Bjerre Knudsen, DMSc, Chief Scientific Advisor, Novo Nordisk
Showing Events in 1 Track from 09:05am to 09:30am
Annual Keynote
9:05AM - 9:30AM
Keynote Innovation Leadership
Speakers:
Robert Langer, ScD, David H. Koch Institute Professor, MIT
Showing Events in 1 Track from 09:30am to 09:45am
Morning General Session Continued
9:30AM - 9:45AM
What's So Special About Specialty Delivery?
Speaker:
Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership
Showing Events in 1 Track from 09:45am to 10:35am
PODD Grand Opening Networking Break & Partnering
9:45AM - 10:35AM
PODD Grand Opening Networking Break & Partnering
Showing Events in 1 Track from 10:35am to 12:25pm
Morning General Session Continued
10:35AM - 10:55AM
A Breath of Opportunities: The Future of Inhaled Biologics
Speaker:
Mireia Puig-Sellart, PharmD, PhD, Manager, Pharmaceutical Development, Phillips Medisize
10:55AM - 11:25AM
Pharma Company Spotlights
Speakers:
Mateja Kramer, PhD, Global Head of Innovation, Novartis
Nicholas Schill, PhD, Senior Director, Landscaping & Platform Definition; Device & Combination Product Development, AbbVie
11:25AM - 11:40AM
Emerging Design Space Requirements in High-Dose Drug Development Pipeline: Dynamics, Challenges and Potential Technology Pathways
Speaker:
Beth McBride DiLauri, Director, Global Marketing, BD
11:40AM - 12:10PM
Partnering to Advance Drug Delivery Innovation
Moderated by:
Ester Caffarel-Salvador, PhD, Director, Strategic Innovation, Chiesi USA
Panelists:
Annette Bak, PhD, MBA, Head of Advanced Drug Delivery, AstraZeneca
Sean Bedingfield, PhD, R&D Advisor - Genetic Medicine, Eli Lilly and Company
Jaymin Shah, PhD, Senior Research Fellow and Head of Biopharmaceutics, Pfizer
Rashmi Thakur, Director, Portfolio Strategy & Integration, BMS
12:10PM - 12:25PM
Reserved Session
Showing Events in 1 Track from 12:25pm to 01:25pm
Luncheon & Partnering Meetings
12:25PM - 1:25PM
Luncheon & Partnering Meetings
Showing Events in 1 Track from 01:25pm to 06:25pm
The 15th Annual PODD Drug Delivery Technology Presentations in Ten Tracks
1:25PM - 6:25PM
The 15th Annual PODD Drug Delivery Technology Presentations in Ten Tracks, to See All Tracks Click the Red Side Arrow Below
Showing Events in 5 Tracks from 01:30pm to 03:52pm
1A: Injectable Formulations & Technologies
Chaired by:
Manish Gupta, PhD, Executive Director R&D, Drug Product Development - Steriles, GSK
1:30PM - 1:45PM
InnoMedica's Liposomal GM1 Drug Against Neurodegenerative Diseases
Speaker:
Andreas Zumbuehl, Scientific Specialist, InnoMedica
1:45PM - 2:00PM
West
2:00PM - 2:15PM
Nanomi’s Multi-Indication Growth Engine to Develop Tailor Made Long Acting Injectables in Pharma
Speaker:
Okke Franssen, PhD, CEO, Nanomi
2:15PM - 2:30PM
Chroniject Technology: A Solution to Long Acting Injectable Formulation and Scale-Up Challenges
Speaker:
Colin Spencer, Head of Technology Transfer, Project Manager, Oakwood Labs
2:30PM - 2:45PM
Simplify to Scale: Reducing Complexity in Dual Drug Formulation and Delivery
Speaker:
Nicolas Bralet, Associate Business Director, Biologics PFS, BD
2:45PM - 3:00PM
Beyond Materials: Corbion as Your Trusted Partner in Innovative Drug Delivery
Speaker:
Bahar Yeniad, PhD, Global Senior Business Development Manager, Corbion
3:00PM - 3:15PM
SynBiosys®: Long-Acting Injectable Microspheres and In Situ Forming Depots for Delivery of Peptides and Proteins
Speaker:
Rob Steendam, PhD, Chief Technology Officer, InnoCore
3:15PM - 3:30PM
Clinical Data on Once-Monthly GLP-1 Formulation Using the PharmaShell Drug Delivery System
Speaker:
David Westberg, CEO, Nanexa
3:30PM - 3:45PM
The Progress in New Drug and Therapy Development Inspire Innovations in Drug Delivery Technologies
Speaker:
Lukasz Koroniak, Global Biomaterial Director Drug Delivery Solutions, dsm-firmenich
3:45PM - 3:52PM
Ripple Therapeutics
Speaker:
Wendy Naimark, PhD, CTO & Co-Founder, Ripple Therapeutics
2A: Oral, Nasal, Pulmonary & Other Non-Injectable Technologies
Chaired by:
Parthiban Rajasekaran, DVM, PhD, Innovation Lead, Sanofi
1:30PM - 1:45PM
Strategic Pipeline Development with Neoliposomal™ Delivery: A Versatile Platform for Enhanced Drug Delivery and Bioavailability
Speaker:
TR Thirucote, Chairman & CEO, TesoRX
1:45PM - 2:00PM
Tailoring Controlled Release of Small Molecules and Biologics via Innovative High-Throughput Electrohydrodynamic Processing
Speaker:
Jose Lagaron, CEO/CSO, BioNanoPharma
2:00PM - 2:15PM
Alginate Oligosaccharide Platform: A Peptide & LNP Delivery Solution for Oral and Inhaled Routes
Speaker:
Yngve Mikkelsen, Chief Medical Officer, AlgiPharma AS
2:15PM - 2:30PM
Tailored Solutions and End-to-End Development for Your Drug–Nebulizer Combination Product
Speaker:
Chris Vernall, EVP Business Development, HCMed
2:30PM - 2:45PM
Syntis Bio
2:45PM - 3:00PM
ARx
3:00PM - 3:15PM
Open Session
3:15PM - 3:30PM
Open Session
3:30PM - 3:45PM
Open Session
3:45PM - 3:52PM
Therakind
3A: Novel Devices: Self-Injectables, Wearables & Connected Devices
Chaired by:
Ulrich Brüggemann, Lead Advanced Drug Delivery Technical Development, Takeda Pharmaceuticals
1:30PM - 1:45PM
Aktiv
1:45PM - 2:00PM
Transforming Chronic Care: How Connected Autoinjectors Improve Outcomes
Speaker:
Greg Panebianco, Sr. Director of Engineering & Customer Success, Flex
2:00PM - 2:15PM
Thinking Outside the Vial: Truly Integrated Drug-Device Developments
Speaker:
Fran Pencliffe, MEng, Healthcare Device Engineer, Cambridge Design Partnership
2:15PM - 2:30PM
Haselmeier
2:30PM - 2:45PM
TTP
2:45PM - 3:00PM
Connected Auto-injectors: Driving Innovation in Drug Delivery and Patient Adherence
Speaker:
Ilan Shopen, Director of Marketing and Business Development, E3D – Elcam Drug Delivery Devices
3:00PM - 3:15PM
A Configurable Patient-Centric autoinjector platform for High Viscosity and Large Volume Delivery
Speakers:
Pete Evans, Director of Device Development, SMC LTD
Asmita Khanolkar, Senior Director, SMC LTD
3:15PM - 3:30PM
Congruence Medical
3:30PM - 3:45PM
Pioneering Ocular Encapsulated Cell Therapy: Integrating Human Factors in the Development of ENCELTO
Speaker:
Claire Young, Senior Human Factors Consultant, Team Consulting
3:45PM - 3:52PM
Smart, Low-Cost Reusable Devices Can Enable Ideal Drug Development TPP
Speaker:
Peter Stebbins, VP, Program and Business Development, Satio
4A: Cell, Gene & Novel Biologics Delivery
Chaired by:
Russell Johnson, PhD, Head of Delivery Sciences, Moderna
1:30PM - 1:45PM
Open Session
1:45PM - 2:00PM
Getting to Scale with Genetic Therapies
Speaker:
Tony Duong, PhD, Lead Drug Delivery Scientist, Battelle
2:00PM - 2:15PM
Formulation Development Platform for Ionizable Lipid Library
Speaker:
Sho Ueno, Research Scientist, NOF CORPORATION
2:15PM - 2:30PM
LipidSol - An Enabler for Delivery of Small Molecules and Biologics
Speaker:
Shaukat Ali, PhD, Senior Director, Scientific Affairs & Technical Marketing, Ascendia Pharmaceuticals
2:30PM - 2:45PM
Transforming Non-Viral Gene Delivery: SENS™ (Selectivity Enabling NanoShell) Unlocks Cell-Selective Targeting of Extrahepatic, and Diseased Tissues
Speaker:
Saudat Fadeyi, PhD, MBA, Head of Business Development & Strategy, Samyang
2:45PM - 3:00PM
Payload Delivery Using Poly(glycerol ester) Polymers
Speaker:
Brian Ginn, PhD, Manager, Biomaterials Research, Secant Group
3:00PM - 3:15PM
Nitto Biopharma
3:15PM - 3:30PM
Manufacturing and Analytical Platform - From pDNA and mRNA to LNP with Multiple Nucleic Acids Loads
Speaker:
Andreja Gramc Livk, Head of Process Analytics, Sartorius BIA Separations
3:30PM - 3:45PM
Open Session
3:45PM - 3:52PM
Non-Viral Genetic Medicine Delivery with polyNaut®: Targeted Polymer Nanovesicles for CNS and Immune Cells
Speaker:
Sam Barker, Chief Business Officer, ViaNautis Bio
5A: Novel Materials & Excipient Innovation
Chaired by:
Edel Mullen, PhD, MBA, BSc, Director Drug Product Technologies, Amgen
1:30PM - 1:45PM
Open Session
1:45PM - 2:00PM
New Long-Acting Injectables and Immunotherapy Therapies Run On Tunable Lactide/Glycolide Polymers
Speaker:
Thomas Tice, Senior Director, Strategic and Technical Marketing, Evonik
2:00PM - 2:15PM
BioHale® Sugars – Micro Molecules, Macro Impact on Biotherapeutics
Speaker:
Mark Wagner, Sales Manager, North America, BioHale Disaccharides and Dry Powder Inhalation, DFE Pharma
2:15PM - 2:30PM
Design for Biocompatibility Strategies for Novel Excipients
Speaker:
Rigwed Tatu, PhD, Extractables and Leachables Program Lead, PSN Labs
2:30PM - 2:45PM
Ligand
2:45PM - 3:00PM
Open Session
3:00PM - 3:15PM
Open Session
3:15PM - 3:30PM
Open Session
3:30PM - 3:45PM
Open Session
3:45PM - 3:52PM
Large Lipid Body (LLB) Technology for Rapid Formulation of Hydrophobic Drugs, and Advantages Over Liposomes
Speaker:
Thomas Kelleher, CEO, Xylome
Showing Events in 1 Track from 03:55pm to 04:10pm
15-Minute Ice Cream & Networking Break
3:55PM - 4:10PM
15-Minute Ice Cream & Networking Break
Showing Events in 5 Tracks from 04:15pm to 06:22pm
1B: Injectable Formulations & Technologies
Chaired by:
F. Javier Muñoz, PhD, MBA, Technology Evaluation Leader, F Hoffmann-La Roche
4:15PM - 4:30PM
G2G Bio
4:30PM - 4:45PM
Surf SnapShot™ Technology: Ultra-Concentrated Subcutaneous Biologics via Standard Manufacturing Processes
Speaker:
Bryan Mazlish, CEO, Surf Bio
4:45PM - 5:00PM
Lipoid
5:00PM - 5:15PM
Nitrogen Dioxide Sterilization, the Leading Alternative to Ethylene Oxide
Speaker:
David Opie, Senior Vice President of Research and Development, Noxilizer
5:15PM - 5:30PM
Overcoming Challenges in Injectable Formulations Through Excipient Choice, Featuring Long-Acting Injectables
Speaker:
Brad Minrovic, PhD, Technical Sales Account Manager, Pharmaceutical Injectables, Ashland Specialty Ingredients
5:30PM - 5:45PM
Launching the First Biosimilar in an On-Body Injector – Lessons From the Device Manufacturer
Speaker:
Andrei Yosef, PhD, President, LTS Device Technologies, LTS-Lohmann
5:45PM - 6:00PM
Curia Global
6:00PM - 6:15PM
DelSiTech
6:15PM - 6:22PM
The Emerging Role of Precision Nanoporous Silicon Dioxide in Drug Delivery
Speaker:
Michael Sailor, PhD, Chief Scientific Officer, SiCare Bio
2B: Novel Injectable & Non-Injectable Technologies
Chaired by:
Jill Steinbach-Rankins, PhD, Senior Associate Director, Innovation Technology, Boehringer Ingelheim
4:15PM - 4:30PM
PharmaJet
Speaker:
Dan Mallon, Senior Vice President, Corporate Development, PharmaJet
4:30PM - 4:45PM
DELOS Nanovesicle Technology for the Development and Manufacture of Nanomedicines: Two Case Studies in Long-Acting Injectables and Nucleic Acid Delivery
Speaker:
Carla Castellar, Scientific Manager, Nanomol
4:45PM - 5:00PM
Implantable Drug Delivery…Are We There Yet?
Speaker:
Breck Petrillo, Sr. Director, Commercial Business Development, Battelle
5:00PM - 5:15PM
Vitaldose® Long-Acting Drug Delivery to Address Unmet Needs in Parenteral and Ocular Applications: Durable and Biodegradable Platforms
Speaker:
Jeff Haley, PhD, Global Technology Manager: VitalDose® and Ateva® Polymers, Celanese
5:15PM - 5:30PM
AI-Driven Development of Biologic Long Acting Injectables
Speaker:
Karthik Raman, PhD, CEO, Persist AI
5:30PM - 5:45PM
Zephyrus Innovations
5:45PM - 6:00PM
Multiphysics Simulation and Specialized Testing in Combination Product Design & Verification: Reducing Patient Risk
Speakers:
Matthew Hancock, PhD, Principal, Veryst Engineering
Sean Teller, PhD, Principal, Veryst Engineering
6:00PM - 6:15PM
Development and Application of Drug Delivery System Platform based on Microfluidic Technologies
Speaker:
Chan Hee Chon, CTO, Inventage Lab
6:15PM - 6:22PM
Open Session – Emerging Company
3B: Novel Device Technologies
Chaired by:
Scott Gibson, Director, Global Operations Leadership, Obesity & Related Conditions, Amgen
4:15PM - 4:30PM
Exploiting the Benefits of Gas Power for Medical Devices: Capacity, Consistency & Control
Speaker:
Jack Auld, Co-CEO & Co-Founder, Altaviz
4:30PM - 4:45PM
Patient-First, Science-Driven: The Rise of Nasal Therapeutics
Speaker:
Reenal Gandhi, Director, Business Development, Aptar Pharma
4:45PM - 5:00PM
Bridging the Clinical to Commercial Gaps for Combination Products
Speakers:
Erik Ferrier, Device and Combination Products, Device & Packaging Technology, Manufacturing Sciences & Technology, BMS
Bill Welch, Executive Director Market Development, PCI Pharma Services
5:00PM - 5:15PM
Large Volume Drug Delivery Devices: Considerations for HCP and Patient Experience
Speaker:
Adam Edelhauser, Director of R&D, KORU Medical Systems
5:15PM - 5:30PM
Addressing the Unmet Need in High-Volume Subcutaneous Self-Administration
Speakers:
Yuki Takeuchi, Global Product Manager for the PLAJEX Ready-to-Fill syringe platform, Terumo
Michael Travanty, Vice President, Product Development Engineering, Halozyme
5:30PM - 5:45PM
A Novel Approach to Modelling Injector Performance and Break-Loose Extrusion Force Data
Speakers:
Deep Bhattacharya, PhD, Principal Scientist, Pfizer
Tom Oakley, Board Member and VP Design and Development,, Sanner Group
5:45PM - 6:00PM
Miniaturization Advancement for Scalable Production Previously Thought Unattainable: Molding Thin Wall Cannulas, Microfluidics, and Micro Needles
Speakers:
Brent Hahn, MBA, SVP, Isometric Micro Molding
6:00PM - 6:15PM
Secant Group
6:15PM - 6:22PM
Precision Matters: Advancing Drug Delivery for Novel Therapies
Speaker:
Steve Duddy, Co-Founder & CEO, Rheotek Medical
4B: Cell, Gene & Novel Biologics Delivery
Chaired by:
Junwei Li, PhD, Innovation Manager, Novo Nordisk
4:15PM - 4:30PM
AI-Designed Polymer Nanoparticles: A New Frontier in Gene Therapy
Speaker:
Shira Orr, PhD, Co-Founder and CEO, Envoya
4:30PM - 4:45PM
Nanoprimer Technology for Enhanced Therapeutic Delivery: Outsmarting the Liver Barrier
Speaker:
Julie Devalliere, PhD, Senior Manager, Biology Team, Nanobiotix
4:45PM - 5:00PM
Re-Vana Therapeutics
5:00PM - 5:15PM
Open Session
5:15PM - 5:30PM
Open Session
5:30PM - 5:45PM
Open Session
5:45PM - 6:00PM
Open Session
6:00PM - 6:15PM
Open Session
6:15PM - 6:22PM
QurCan Therapeutics
5B: Self-Injection Devices, Syringes, Primary Container & Packaging Solutions
Chaired by:
Srini Sridharan, PhD, Executive Director, Drug Delivery & Product Integration, Bristol-Myers Squibb
4:15PM - 4:30PM
Kindeva
4:30PM - 4:45PM
Advantages of a Delivery System Platform to Drug-Device Combination Product Development
Speaker:
Laxman Halleppanavar, Head of Portfolio Strategy and Management, Credence MedSystems
4:45PM - 5:00PM
De-Risking Autoinjector Integration with High-Performance Pre-Fillable Syringes
Speaker:
Alessio Bonati, Director Alba & Nexa Flex Programs, Stevenato Group
5:00PM - 5:15PM
Practical Strategy and Execution to Achieve Success with a Novel Combination Product
Speaker:
Jonathan Amaya-Hodges, Consulting Director, Suttons Creek
5:15PM - 5:30PM
OXYCAPT™ Vial & Syringe: High Gas Barrier Plastic Container for Biologics and Cell & Gene Therapy Products Sorted with Dry Ice or LN2
Speaker:
Masashi Miura, Researcher, Mitsubishi Gas Chemical
5:30PM - 5:45PM
The Design of a Large Volume PFS-Based Autoinjector Considering the Patient`s Perspective
Speakers:
Bernd Mahlmann, MBA, Associate Director, Account & Business Development, Ypsomed
Daniele Tartini, Sr. Business Development Manager – Glass Syringes, SCHOTT Pharma USA
5:45PM - 6:00PM
RPK
6:00PM - 6:15PM
Joined-Up Thinking: Combining Drug Product and Device Development and Manufacturing for a Fast and Assured Route to Market
Speaker:
Oliver Eden, MEng (Hons), PhD, Senior Business Unit Director, Jabil Healthcare
6:15PM - 6:22PM
Weiss-Aug/RX Bandz
Showing Events in 1 Track from 06:25pm to 07:30pm
PODD Networking Reception & Partnering Meetings
6:25PM - 7:30PM
PODD Networking Reception & Partnering Meetings
Showing Events in 1 Track from 07:30pm to 07:30pm
Day One Concludes
7:30PM - 7:30PM
Day One Concludes
Previous
Day One
Monday, October 27, 2025

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.